Insulet Stock Analysis

Insulet Stock Analysis Notes

About 100.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.19. Insulet had not issued any dividends in recent years. Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. Insulet Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2300 people. To find out more about Insulet contact James Hollingshead at 978 600 7000 or learn more at https://www.insulet.com.

Insulet Investment Alerts

Insulet Upcoming and Recent Events

Insulet Largest EPS Surprises

View All Earnings Estimates

Insulet Environmental, Social, and Governance (ESG) Scores

Insulet Thematic Classifications

Insulet Stock Institutional Investors

Note, although Insulet's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Insulet Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 20.72 B.

Insulet Profitablity

The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17.

Management Efficiency

Insulet has return on total asset (ROA) of 0.0874 % which means that it generated a profit of $0.0874 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1968 %, meaning that it created $0.1968 on every $100 dollars invested by stockholders. Insulet's management efficiency ratios could be used to measure how well Insulet manages its routine affairs as well as how well it operates its assets and liabilities. At present, Insulet's Return On Equity is projected to increase slightly based on the last few years of reporting. At present, Insulet's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 1.5 B, whereas Return On Tangible Assets are forecasted to decline to 0.13.

Technical Drivers

As of the 7th of January, Insulet retains the Standard Deviation of 2.18, risk adjusted performance of (0.02), and Market Risk Adjusted Performance of (0.08). Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Insulet, as well as the relationship between them. Please check out Insulet information ratio, and the relationship between the coefficient of variation and value at risk to decide if Insulet is priced fairly, providing market reflects its last-minute price of 297.32 per share. Given that Insulet has information ratio of (0.07), we strongly advise you to confirm Insulet's regular market performance to make sure the company can sustain itself at a future point.

Insulet Price Movement Analysis

Insulet Insider Trading Activities

Insulet Outstanding Bonds

Insulet Predictive Daily Indicators

Insulet Corporate Filings

Insulet Forecast Models

Insulet's time-series forecasting models are one of many Insulet's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Insulet's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Insulet Bond Ratings

Insulet financial ratings play a critical role in determining how much Insulet have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Insulet's borrowing costs.

Insulet Debt to Cash Allocation

Insulet currently holds 1.42 B in liabilities with Debt to Equity (D/E) ratio of 3.34, implying the company greatly relies on financing operations through barrowing. Insulet has a current ratio of 4.6, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Insulet's use of debt, we should always consider it together with its cash and equity.

Insulet Total Assets Over Time

Insulet Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Insulet uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Insulet Debt Ratio

42.0

It looks as if about 58% of Insulet's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Insulet's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Insulet, which in turn will lower the firm's financial flexibility.

Insulet Corporate Bonds Issued

Insulet Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how Insulet prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Insulet shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Insulet. By using and applying Insulet Stock analysis, traders can create a robust methodology for identifying Insulet entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Insulet analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Insulet analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Insulet stock analysis indicators help investors evaluate how Insulet stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Insulet shares will generate the highest return on investment. By understating and applying Insulet stock analysis, traders can identify Insulet position entry and exit signals to maximize returns.

When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.